If you would like to be added to the news release distribution list, please fill out the email alerts form here
| May 14 2012 | Helix BioPharma Corp. Commences Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 |
|---|---|
| May 7 2012 | Helix BioPharma Corp. Updates Shareholders on Court Approval of Settlement |
| May 3, 2012 | Helix BioPharma Corp. Updates Shareholders On Election Of Directors |
| April 5, 2012 | Helix BioPharma Corp. Reconstituted Board of Directors Provides Update To Shareholders |
| March 16, 2012 |
Helix BioPharma Corp. Announces Q2 2012 Results: Confirms Reconstituted Board of Directors |
| March 14, 2012 | Helix BioPharma Corp. Announces Agreed Changes To The Board Of Directors And Settlement With Concerned Shareholders |
| March 1, 2012 | Helix BioPharma Corp. announces L-DOS47 Scientific Presentation to be made at the Second Annual IBC Conference on Analytical Technologies Biotherapeutic Development |
| January 30, 2012 | Helix BioPharma Corp. Updates Shareholders on Results From Annual General Meeting |
| January 25, 2012 | Special Committee Of Helix BioPharma Corp. Provides Update To Shareholders |
| January 23, 2012 | Helix BioPharma Corp. Announces that Institutional Shareholder Services Recommends Shareholders Vote for Management’s Director Nominees |
| January 23, 2012 | Helix BioPharma Corp. Responds To Dissident Proxy Circular In Connection With The January 30, 2012 Shareholder Meeting |
| January 13, 2012 | Helix BioPharma Corp. Announces Q1 2012 Results |
| January 9, 2012 | Helix BioPharma Corp. Appoints Jack Kay As Chairman Of The Board And Professor Kazimierz Roszkowski- Śliż As European Medical Director |
| January 6, 2012 | Helix BioPharma Corp. Proposes New Board Slate For January 30, 2012 Annual General Meeting |
| December 22, 2011 | Helix BioPharma Corp. Files Clinical Trial Applications For Its Planned European Phase III Efficacy Trial Of Topical Interferon Alpha-2B In Patients With Low-Grade Cervical Lesions |
| December 6, 2011 |
The Special Committee of Helix BioPharma Corp. Provides Update to Shareholders |
| November 16, 2011 | Helix BioPharma Corp. Announces Appointment of Special Committee |
| November 11, 2011 | Clinical Hold Removed For Helix BioPharma Corp.’S Topical Interferon Alpha-2b Phase II/III Efficacy Trial IND Application |
| November 7, 2011 | Helix BioPharma Corp. Announces Meeting of Shareholders |
| October 31, 2011 | Helix BioPharma Corp. Announces Fiscal 2011 Results |
| October 20, 2011 | Helix BioPharma Corp. Terminates Agreement with ACM Alpha Consulting Management Est. |
| October 18, 2011 | Helix BioPharma Corp. Receives Shareholder Requisition to Hold Meeting To Elect Directors |
| October 12, 2011 |
Helix BioPharma Corp. Files IND Clinical Hold Response With FDA For Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial |